Literature DB >> 25875802

A literature review on the patients with autoimmune diseases following vaccination against infections.

Yan Liang1, Fan-Ya Meng, Hai-Feng Pan, Dong-Qing Ye.   

Abstract

Due to immune abnormalities and the use of steroids and immunosuppressant treatment, patients with rheumatic diseases are susceptible to infections. Vaccination is one of the most important prevention tools in modern medicine. A discussion on risk-benefit or cost-benefit analysis, and advisory on individual vaccines or vaccination programs falls outside the scope of this review. In particularly, this review summarizes the knowledge about the effectiveness and safety vaccinations in patients with autoimmune inflammatory rheumatic diseases (AIIRD) treated with biologics. Finally, we aim to provide vaccination plans basis for clinical management of rheumatic patients depending upon prevaccination antibody titers, drug treatments and immunological potential.

Entities:  

Keywords:  autoimmune diseases; biologics; infections; vaccination

Mesh：

Substances：

Year:  2015        PMID： 25875802      PMCID： PMC4635701          DOI： 10.1080/21645515.2015.1009337

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  67 in total

1.  Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs.

Authors:  Meliha Crnkic Kapetanovic; Carmen Roseman; Göran Jönsson; Lennart Truedsson
Journal:  Clin Rheumatol       Date:  2011-09-29       Impact factor: 2.980

2.  Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.

Authors:  M C Kapetanovic; T Saxne; J-A Nilsson; P Geborek
Journal:  Rheumatology (Oxford)       Date:  2006-11-18       Impact factor: 7.580

3.  Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab.

Authors:  L B S Gelinck; Y K O Teng; G F Rimmelzwaan; B J F van den Bemt; F P Kroon; J M van Laar
Journal:  Ann Rheum Dis       Date:  2007-10       Impact factor: 19.103

4.  Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.

Authors:  Jan D Lünemann; Mar Tintoré; Brady Messmer; Till Strowig; Alex Rovira; Héctor Perkal; Estrella Caballero; Christian Münz; Xavier Montalban; Manuel Comabella
Journal:  Ann Neurol       Date:  2010-02       Impact factor: 10.422

Review 5.  Autoimmune disease: A role for new anti-viral therapies?

Authors:  David H Dreyfus
Journal:  Autoimmun Rev       Date:  2011-08-18       Impact factor: 9.754

Review 6.  A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review.

Authors:  M R Geier; D A Geier
Journal:  Clin Exp Rheumatol       Date:  2004 Nov-Dec       Impact factor: 4.473

7.  Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.

Authors:  Sherry R Crowe; Joan T Merrill; Evan S Vista; Amy B Dedeke; David M Thompson; Scott Stewart; Joel M Guthridge; Timothy B Niewold; Beverly S Franek; Gillian M Air; Linda F Thompson; Judith A James
Journal:  Arthritis Rheum       Date:  2011-08

8.  Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation.

Authors:  A J Tingle; M Allen; R E Petty; G D Kettyls; J K Chantler
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

9.  A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database.

Authors:  D A Geier; M R Geier
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

10.  Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Authors:  Clifton O Bingham; R John Looney; Atul Deodhar; Neal Halsey; Maria Greenwald; Christine Codding; Benjamin Trzaskoma; Flavius Martin; Sunil Agarwal; Ariella Kelman
Journal:  Arthritis Rheum       Date:  2010-01
View more
  4 in total

Review 1.  IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.

Authors:  Raghu Patil Junjappa; Prakash Patil; Kashi Raj Bhattarai; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 7.561

2.  Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders.

Authors:  Charlene Y C Chau; Loraine L W Chow; Siddharth Sridhar; Kendrick C Shih
Journal:  Ophthalmol Ther       Date:  2021-03-06

Review 3.  The Eye of the Storm: COVID-19 Vaccination and the Eye.

Authors:  Xin Le Ng; Bjorn Kaijun Betzler; Sean Ng; Soon Phaik Chee; Lakshminarayanan Rajamani; Amit Singhal; Andres Rousselot; Carlos E Pavesio; Vishali Gupta; Marc D de Smet; Rupesh Agrawal
Journal:  Ophthalmol Ther       Date:  2021-12-16

4.  A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections.

Authors:  Milomir S Milanovic; Djordje M Kadijevich; Ljudmila Stojanovich; Branislav Milovanovic; Aleksandra Djokovic
Journal:  Medicina (Kaunas)       Date:  2022-01-04       Impact factor: 2.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.